{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:43:42Z","timestamp":1790631822345,"version":"4.1.0"},"reference-count":63,"publisher":"Impact Journals, LLC","issue":"15","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2015,5,30]]},"DOI":"10.18632\/oncotarget.3830","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T06:31:59Z","timestamp":1442298719000},"page":"13772-13789","source":"Crossref","is-referenced-by-count":151,"title":["Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation"],"prefix":"10.18632","volume":"6","author":[{"given":"Lavinia","family":"Raimondi","sequence":"first","affiliation":[{"name":"Laboratory of Tissue Engineering - Innovative Technology Platforms for Tissue Engineering (PON01-00829), Rizzoli Orthopedic Institute, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"De Luca","sequence":"additional","affiliation":[{"name":"Laboratory of Tissue Engineering - Innovative Technology Platforms for Tissue Engineering (PON01-00829), Rizzoli Orthopedic Institute, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Amodio","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Manno","sequence":"additional","affiliation":[{"name":"Institute of Biophysics, National Research Council of Italy, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Raccosta","sequence":"additional","affiliation":[{"name":"Institute of Biophysics, National Research Council of Italy, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Taverna","sequence":"additional","affiliation":[{"name":"Section of Biology and Genetics, Department of Biopathology and Medical Biotechnology, University of Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Bellavia","sequence":"additional","affiliation":[{"name":"Laboratory of Tissue Engineering - Innovative Technology Platforms for Tissue Engineering (PON01-00829), Rizzoli Orthopedic Institute, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flores","family":"Naselli","sequence":"additional","affiliation":[{"name":"Section of Biology and Genetics, Department of Biopathology and Medical Biotechnology, University of Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Fontana","sequence":"additional","affiliation":[{"name":"Section of Biology and Genetics, Department of Biopathology and Medical Biotechnology, University of Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odessa","family":"Schillaci","sequence":"additional","affiliation":[{"name":"Section of Biology and Genetics, Department of Biopathology and Medical Biotechnology, University of Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giardino","sequence":"additional","affiliation":[{"name":"Rizzoli Orthopedic Institute, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Fini","sequence":"additional","affiliation":[{"name":"Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University and Medical Oncology Unit, T. Campanella Cancer Center, Salvatore Venuta University Campus, Catanzaro, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Santoro","sequence":"additional","affiliation":[{"name":"Divisione di Ematologia A.O. Ospedali Riuniti Villa Sofia-Cervello, Palermo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"De Leo","sequence":"additional","affiliation":[{"name":"Section of Biology and Genetics, Department of Biopathology and Medical Biotechnology, University of Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Giavaresi","sequence":"additional","affiliation":[{"name":"Laboratory of Tissue Engineering - Innovative Technology Platforms for Tissue Engineering (PON01-00829), Rizzoli Orthopedic Institute, Palermo, Italy"},{"name":"Laboratory of Preclinical and Surgical Studies, Rizzoli Orthopedic Institute, Bologna, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Alessandro","sequence":"additional","affiliation":[{"name":"Section of Biology and Genetics, Department of Biopathology and Medical Biotechnology, University of Palermo, Italy"},{"name":"Institute of Biomedicine and Molecular Immunology (IBIM), National Research Council of Italy, Palermo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2015,4,12]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1158\/1078-0432.CCR-10-1804","article-title":"Advances in the biology and treatment of bone disease in multiple myeloma","volume":"17","author":"Roodman","year":"2011","journal-title":"Clin Cancer Res"},{"key":"2","first-page":"33","article-title":"Bone disease in multiple myeloma: pathophysiology and management","volume":"7","author":"O'Gorman","year":"2014","journal-title":"Cancer Growth Metastasis"},{"key":"3","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/156800912802429300","article-title":"Molecular targets for the treatment of multiple myeloma","volume":"12","author":"Caraglia","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"4","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1182\/blood-2012-06-434019","article-title":"CCR1 blockade and myeloma bone disease","volume":"120","author":"Sebag","year":"2012","journal-title":"Blood"},{"key":"5","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1200\/JCO.2010.32.5449","article-title":"Advances in imaging and the management of myeloma bone disease","volume":"29","author":"Dimopoulos","year":"2011","journal-title":"J Clin Oncol"},{"key":"6","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1158\/1078-0432.CCR-12-1708","article-title":"Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma:andevidence","volume":"18","author":"Shammas","year":"2012","journal-title":"Clin Cancer Res"},{"key":"7","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.3109\/10428194.2013.788699","article-title":"Revisiting treatment paradigms in high-risk smoldering multiple myeloma: out with the old, in with the new?","volume":"54","author":"Ghobrial","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"8","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jcp.24306","article-title":"miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease","volume":"228","author":"Tassone","year":"2013","journal-title":"J Cell Physiol"},{"key":"9","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/j.ejca.2005.11.034","article-title":"Bone markers in multiple myeloma","volume":"42","author":"Sezer","year":"2006","journal-title":"Eur J Cancer"},{"key":"10","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2013.385","article-title":"Bone marrow monocyte-\/macrophage-derived activin A mediates the osteoclastogenic effect of IL-3 in multiple myeloma","volume":"28","author":"Giuliani","year":"2014","journal-title":"Leukemia"},{"key":"11","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1182\/blood-2003-11-3839","article-title":"Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: a vicious cycle between bone destruction and myeloma expansion","volume":"104","author":"Matsumoto","year":"2004","journal-title":"Blood"},{"key":"12","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa030847","article-title":"The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma","volume":"349","author":"Shaughnessy","year":"2003","journal-title":"N Engl J Med"},{"key":"13","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1073\/pnas.96.7.3540","article-title":"Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand","volume":"96","author":"Scully","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.201394498","article-title":"Multiple myeloma disrupts the TRANCE\/osteoprotegerin cytokine axis to trigger bone destruction and promote tumor progression","volume":"98","author":"Choi","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"15","doi-asserted-by":"crossref","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","article-title":"Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment","volume":"98","author":"Barille","year":"2001","journal-title":"Blood"},{"key":"16","doi-asserted-by":"crossref","first-page":"10905","DOI":"10.1073\/pnas.200294797","article-title":"Diverse roles of the tumor necrosis factor family member TRANCE in skeletal physiology revealed by TRANCE deficiency and partial rescue by a lymphocyte-expressed TRANCE transgene","volume":"97","author":"Choi","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"17","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.semcancer.2011.01.002","article-title":"The secreted factors responsible for pre-metastatic niche formation: old sayings and new thoughts","volume":"21","author":"Lyden","year":"2011","journal-title":"Semin Cancer Biol"},{"key":"18","doi-asserted-by":"crossref","first-page":"5338","DOI":"10.3390\/ijms14035338","article-title":"Exosomes as intercellular signaling organelles involved in health and disease: basic science and clinical applications","volume":"14","author":"Alessandro","year":"2013","journal-title":"Int J Mol Sci"},{"key":"19","doi-asserted-by":"crossref","first-page":"e5219","DOI":"10.1371\/journal.pone.0005219","article-title":"High levels of exosomes expressing CD63 and caveolin-1 in plasma of melanoma patients","volume":"4","author":"Maio","year":"2009","journal-title":"PLoS One"},{"key":"20","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ejca.2013.01.017","article-title":"Exosomes from triple-negative breast cancer cells can transfer phenotypic traits representing their cells of origin to secondary cells","volume":"49","author":"O'Driscoll","year":"2013","journal-title":"Eur J Cancer"},{"key":"21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s00109-013-1020-6","article-title":"Exosomes in tumor microenvironment influence cancer progression and metastasis","volume":"91","author":"Kalluri","year":"2013","journal-title":"J Mol Med (Berl)"},{"key":"22","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood-2014-03-562439","article-title":"Bone marrow stromal cell-derived exosomes as communicators in drug resistance in multiple myeloma cells","volume":"124","author":"Menu","year":"2014","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"5686","DOI":"10.18632\/oncotarget.2159","article-title":"Multiple myeloma dell-derived microvesicles are enriched in CD147 expression and enhance tumor cell proliferation","volume":"5","author":"Jelinek","year":"2014","journal-title":"Oncotarget"},{"key":"24","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1242\/jcs.115.12.2505","article-title":"The exosome pathway in K562 cells is regulated by Rab11","volume":"115","author":"Colombo","year":"2002","journal-title":"J Cell Sci"},{"key":"25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1002\/jcp.20770","article-title":"Active caspase-3 is required for osteoclast differentiation","volume":"209","author":"Steinbeck","year":"2006","journal-title":"J Cell Physiol"},{"key":"26","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1158\/0008-5472.CAN-03-1131","article-title":"Cancer and the microenvironment: myeloma-osteoclast interactions as a model","volume":"64","author":"Epstein","year":"2004","journal-title":"Cancer Res"},{"key":"27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.bcmd.2004.01.001","article-title":"Pathogenesis of myeloma bone disease","volume":"32","author":"Roodman","year":"2004","journal-title":"Blood Cells Mol Dis"},{"key":"28","doi-asserted-by":"crossref","first-page":"e32444","DOI":"10.1371\/journal.pone.0032444","article-title":"The tempered polymerization of human neuroserpin","volume":"7","author":"Manno","year":"2012","journal-title":"PLoS One"},{"key":"29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/1471-2407-11-108","article-title":"Interaction and uptake of exosomes by ovarian cancer cells","volume":"11","author":"Costa","year":"2011","journal-title":"BMC Cancer"},{"key":"30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1600-0854.2010.01041.x","article-title":"Cellular internalization of exosomes occurs through phagocytosis","volume":"11","author":"Sui","year":"2010","journal-title":"Traffic"},{"key":"31","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/aps.2013.141","article-title":"Microvesicles secreted from human multiple myeloma cells promote angiogenesis","volume":"35","author":"Li","year":"2014","journal-title":"Acta Pharmacol Sin"},{"key":"32","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.1074\/jbc.M010153200","article-title":"Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis","volume":"276","author":"Osdoby","year":"2001","journal-title":"J Biol Chem"},{"key":"33","doi-asserted-by":"crossref","first-page":"3016","DOI":"10.1200\/JCO.2010.32.7312","article-title":"Tandem autologous\/reduced-intensity conditioning allogeneic stem-cell transplantation versus autologous transplantation in myeloma: long-term follow-up","volume":"29","author":"Niederwieser","year":"2011","journal-title":"J Clin Oncol"},{"key":"34","first-page":"vii","article-title":"The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies","volume":"21","author":"Anderson","year":"2007","journal-title":"Hematol Oncol Clin North Am"},{"key":"35","first-page":"345","article-title":"Multiple myeloma bone marrow niche","volume":"10","author":"Carrier","year":"2009","journal-title":"Curr Pharm Biotechnol"},{"key":"36","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1172\/JCI66517","article-title":"BM mesenchymal stromal cell-derived exosomes facilitate multiple myeloma progression","volume":"123","author":"Ghobrial","year":"2013","journal-title":"J Clin Invest"},{"key":"37","doi-asserted-by":"crossref","first-page":"3748","DOI":"10.1182\/blood-2014-05-576116","article-title":"Exosomal miR-135b shed from hypoxic multiple myeloma cells enhances angiogenesis by targeting factor-inhibiting HIF-1","volume":"124","author":"Ohyashiki","year":"2014","journal-title":"Blood"},{"key":"38","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.18632\/oncotarget.1747","article-title":"Targeting of multiple myeloma-related angiogenesis by miR-199a-5p mimics:andanti-tumor activity","volume":"5","author":"Tassone","year":"2014","journal-title":"Oncotarget"},{"key":"39","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1038\/leu.2013.24","article-title":"Hypoxia-inducible factor (HIF)-1 alpha suppression in myeloma cells blocks tumoral growthinhibiting angiogenesis and bone destruction","volume":"27","author":"Neri","year":"2013","journal-title":"Leukemia"},{"issue":"Suppl 1","key":"40","first-page":"S125","article-title":"Non-coding RNA: a novel opportunity for the personalized treatment of multiple myeloma","volume":"13","author":"Tassone","year":"2013","journal-title":"Expert Opin Biol Ther"},{"key":"41","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1002\/jcp.24669","article-title":"A p53-Dependent Tumor Suppressor Network Is Induced by Selective miR-125a-5p Inhibition in Multiple Myeloma Cells","volume":"229","author":"Amodio","year":"2014","journal-title":"Journal of Cellular Physiology"},{"key":"42","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.18632\/oncotarget.675","article-title":"DNA-demethylating and anti-tumor activity of synthetic miR-29b mimics in multiple myeloma","volume":"3","author":"Tassone","year":"2012","journal-title":"Oncotarget"},{"key":"43","doi-asserted-by":"crossref","first-page":"3650","DOI":"10.4161\/cc.26585","article-title":"miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells","volume":"12","author":"Tassone","year":"2013","journal-title":"Cell Cycle"},{"key":"44","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2174\/156800912802429355","article-title":"Promises and challenges of MicroRNA-based treatment of multiple myeloma","volume":"12","author":"Tassone","year":"2012","journal-title":"Curr Cancer Drug Targets"},{"key":"45","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1046\/j.1365-2141.2002.03257.x","article-title":"Myeloma interacts with the bone marrow microenvironment to induce osteoclastogenesis and is dependent on osteoclast activity","volume":"116","author":"Epstein","year":"2002","journal-title":"Br J Haematol"},{"key":"46","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.bone.2005.01.021","article-title":"Stromal cell-derived factor-1 binding to its chemokine receptor CXCR4 on precursor cells promotes the chemotactic recruitment, development and survival of human osteoclasts","volume":"36","author":"Osdoby","year":"2005","journal-title":"Bone"},{"key":"47","first-page":"232546","article-title":"Implications of heterogeneity in multiple myeloma","volume":"2014","author":"Chng","year":"2014","journal-title":"Biomed Res Int"},{"key":"48","doi-asserted-by":"crossref","first-page":"5872","DOI":"10.1074\/jbc.270.11.5872","article-title":"Matrix metalloproteinase-2 is an interstitial collagenase. Inhibitor-free enzyme catalyzes the cleavage of collagen fibrils and soluble native type I collagen generating the specific 3\/4- and 1\/4-length fragments","volume":"270","author":"Quigley","year":"1995","journal-title":"J Biol Chem"},{"key":"49","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1210\/endo.139.3.5818","article-title":"Regulation of matrix metalloproteinases (MMP-2, -3, -9, and -13) by interleukin-1 and interleukin-6 in mouse calvaria: association of MMP induction with bone resorption","volume":"139","author":"Suda","year":"1998","journal-title":"Endocrinology"},{"key":"50","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrrheum.2011.77","article-title":"Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis","volume":"7","author":"Bilezikian","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"51","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.1182\/blood-2006-05-026112","article-title":"Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition","volume":"108","author":"Roodman","year":"2006","journal-title":"Blood"},{"key":"52","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/1471-2407-13-605","article-title":"Molecular signaling pathways mediating osteoclastogenesis induced by prostate cancer cells","volume":"13","author":"Komarova","year":"2013","journal-title":"BMC Cancer"},{"key":"53","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1749-6632.2011.06283.x","article-title":"The osteoclast and its unique cytoskeleton","volume":"1240","author":"Teitelbaum","year":"2011","journal-title":"Ann N Y Acad Sci"},{"key":"54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2011.06249.x","article-title":"How are osteoclasts induced to resorb bone?","volume":"1240","author":"Fuller","year":"2011","journal-title":"Ann N Y Acad Sci"},{"issue":"5484","key":"55","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1126\/science.289.5484.1504","article-title":"Bone resorption by osteoclasts","volume":"289","author":"Teitelbaum","year":"2000","journal-title":"Science"},{"key":"56","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1023\/B:APPT.0000045780.10463.c6","article-title":"Ranking the role of RANK ligand in apoptosis","volume":"9","author":"Aggarwal","year":"2004","journal-title":"Apoptosis"},{"key":"57","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/j.0105-2896.2005.00336.x","article-title":"Osteoclast precursors, RANKL\/RANK, and immunology","volume":"208","author":"Boyce","year":"2005","journal-title":"Immunol Rev"},{"key":"58","first-page":"3013","article-title":"Characterization of multiple myeloma vesicles by label-free relative quantitation","volume":"13","author":"Pichiorri","year":"2013","journal-title":"Proteomics"},{"key":"59","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1471-2407-9-102","article-title":"Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis","volume":"9","author":"Yuan","year":"2009","journal-title":"BMC Cancer"},{"key":"60","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1002\/ijc.26217","article-title":"Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis","volume":"130","author":"Alessandro","year":"2012","journal-title":"Int J Cancer"},{"key":"61","article-title":"Isolation and characterization of exosomes from cell culture supernatants and biological fluids","author":"Clayton","year":"2006","journal-title":"Curr Protoc Cell Biol"},{"key":"62","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.canlet.2014.03.009","article-title":"Exosome-mediated crosstalk between chronic myelogenous leukemia cells and human bone marrow stromal cells triggers an interleukin 8-dependent survival of leukemia cells","volume":"348","author":"Alessandro","year":"2014","journal-title":"Cancer Lett"},{"key":"63","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/1476-4598-13-169","article-title":"Exosomal shuttling of miR-126 in endothelial cells modulates adhesive and migratory abilities of chronic myelogenous leukemia cells","volume":"13","author":"Alessandro","year":"2014","journal-title":"Mol Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,21]],"date-time":"2022-05-21T21:08:20Z","timestamp":1653167300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.3830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,12]]},"references-count":63,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2015,5,30]]}},"alternative-id":["3830","25944696"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.3830","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,12]]}}}